Showing results (141-150 of 191) with videos related to

Sort By:
Pageof 20
Bioorganic & Medicinal Chemistry|March 17, 2020
A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluationMohammed I El-Gamal, Seyed-Omar Zaraei, Paul A Foster, et al.
European Journal of Medicinal Chemistry|January 11, 2020
Diarylamides in anticancer drug discovery: A review of pre-clinical and clinical investigationsAbduelmula R Abduelkarem, Hanan S Anbar, Seyed-Omar Zaraei, et al.
Science (New York, N.Y.)|April 18, 2009
A contemporary microbially maintained subglacial ferrous "ocean"Jill A Mikucki, Ann Pearson, David T Johnston, et al.
Astrobiology|September 14, 2012
LIFE: Life Investigation For Enceladus A Sample Return Mission Concept in Search for Evidence of LifePeter Tsou, Donald E Brownlee, Christopher P McKay, et al.
Expert Opinion on Therapeutic Patents|March 30, 2021
Steroid sulfatase inhibitors: the current landscapeHanan S Anbar, Zahraa Isa, Jana J Elounais, et al.
Archiv Der Pharmazie|June 29, 2024
An overview of the latest outlook of sulfamate derivatives as anticancer candidates (2020-2024)Esra M Mustafa, Afnan I Shahin, Aishah S Alrashed, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 21, 2022
Upadacitinib protects against cisplatin-induced renal and hepatic dysfunction without impairing its anticancer activityHanan S Anbar, Naglaa G Shehab, Nadia M M El-Rouby, et al.
Indian Journal of Dermatology, Venereology and Leprology|December 27, 2011
The effect of H₁ and H₂ receptor antagonists on melanogenesisTag S Anbar, Wiete Westerhof, Nafisa A Badawy, et al.
Bioorganic Chemistry|March 28, 2026
Design and synthesis of novel piperazine-based sulfamate derivatives as steroid sulfatase inhibitorsAnil Ravi, Paul A Foster, Seyed-Omar Zaraei, et al.
Pageof 20